Technetium -H7ND is one of 54 small molecule programs targeting Metastasis. It is currently in Phase 2.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
62 competitors in Metastasis
Blenoxane
Verzenio
Camptosar
Gemzar
Femara
Norvir
Lynparza
Neoral
Tukysa
Zometa
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details